Viewing StudyNCT00411528



Ignite Creation Date: 2024-05-05 @ 5:15 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00411528
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2006-12-12

Brief Title: Efficacy and Safety of Patupilone in Men 18 Years With Metastatic Hormone Refractory Prostate Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Metastatic Hormone Refractory Prostate Cancer
Keywords:
Name View
docetaxel View
Prostate Cancer View
Hormone Refractory View
patupilone View